SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-112507
Filing Date
2014-03-24
Accepted
2014-03-24 17:14:03
Documents
9
Period of Report
2014-05-07
Effectiveness Date
2014-03-24

Document Format Files

Seq Description Document Type Size
1 DEFINITVE PROXY STATEMENT d690615ddef14a.htm DEF 14A 1320158
2 GRAPHIC g690615g63u43.jpg GRAPHIC 22634
3 GRAPHIC g690615g65e37.jpg GRAPHIC 8181
4 GRAPHIC g690615g66t07.jpg GRAPHIC 26608
5 GRAPHIC g690615g87i03.jpg GRAPHIC 11709
6 GRAPHIC g690615g89y23.jpg GRAPHIC 8010
7 GRAPHIC g690615g96n60.jpg GRAPHIC 27830
8 GRAPHIC g690615image001.jpg GRAPHIC 145966
9 GRAPHIC g690615img2.jpg GRAPHIC 108388
  Complete submission text file 0001193125-14-112507.txt   1817441
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19731 | Film No.: 14713827
SIC: 2836 Biological Products, (No Diagnostic Substances)